These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1430 related articles for article (PubMed ID: 33946747)

  • 41. Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break - Chicago, Illinois, March-May 2021.
    Doyle K; Teran RA; Reefhuis J; Kerins JL; Qiu X; Green SJ; Choi H; Madni SA; Kamal N; Landon E; Albert RC; Pacilli M; Furtado LE; Hayden MK; Kunstman KJ; Bethel C; Megger L; Fricchione MJ; Ghinai I
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1195-1200. PubMed ID: 34473687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic diversity of SARS-CoV-2 in Oxford during United Kingdom's first national lockdown.
    Munis AM; Andersson M; Mobbs A; Hyde SC; Gill DR
    Sci Rep; 2021 Nov; 11(1):21484. PubMed ID: 34728747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel SARS-CoV-2 Variants in Italy: The Role of Veterinary Public Health Institutes.
    Lorusso A; Calistri P; Savini G; Morelli D; Ambrosij L; Migliorati G; D'Alterio N
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33806104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bondi and beyond. Lessons from three waves of COVID-19 from 2020.
    Capon A; Sheppeard V; Gonzalez N; Draper J; Zhu A; Browne M; Sullivan E; Mihajlovic M; Rockett R; Ferson MJ
    Public Health Res Pract; 2021 Sep; 31(3):. PubMed ID: 34494077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs.
    Calistri P; Amato L; Puglia I; Cito F; Di Giuseppe A; Danzetta ML; Morelli D; Di Domenico M; Caporale M; Scialabba S; Portanti O; Curini V; Perletta F; Cammà C; Ancora M; Savini G; Migliorati G; D'Alterio N; Lorusso A
    Int J Infect Dis; 2021 Apr; 105():753-755. PubMed ID: 33684558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular epidemiology of SARS-CoV-2 in Cyprus.
    Richter J; Fanis P; Tryfonos C; Koptides D; Krashias G; Bashiardes S; Hadjisavvas A; Loizidou M; Oulas A; Alexandrou D; Kalakouta O; Panayiotidis MI; Spyrou GM; Christodoulou C
    PLoS One; 2021; 16(7):e0248792. PubMed ID: 34288921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soccer in the time of COVID-19: 1 year report from an Italian top league club, March 2020-February 2021.
    Spinicci M; Pengue L; Bartolozzi D; Quercioli M; Epifani F; Pollini S; Zammarchi L; Maria Rossolini G; Bartoloni A
    Epidemiol Infect; 2021 Sep; 149():e207. PubMed ID: 34494512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia.
    Everett J; Hokama P; Roche AM; Reddy S; Hwang Y; Kessler L; Glascock A; Li Y; Whelan JN; Weiss SR; Sherrill-Mix S; McCormick K; Whiteside SA; Graham-Wooten J; Khatib LA; Fitzgerald AS; Collman RG; Bushman F
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid Spread of SARS-CoV-2 in a State Prison After Introduction by Newly Transferred Incarcerated Persons - Wisconsin, August 14-October 22, 2020.
    Hershow RB; Segaloff HE; Shockey AC; Florek KR; Murphy SK; DuBose W; Schaeffer TL; Powell Mph JA; Gayle K; Lambert L; Schwitters A; Clarke KEN; Westergaard R
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(13):478-482. PubMed ID: 33793462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transmission route and introduction of pandemic SARS-CoV-2 between China, Italy, and Spain.
    Nabil B; Sabrina B; Abdelhakim B
    J Med Virol; 2021 Jan; 93(1):564-568. PubMed ID: 32697346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.
    Hodcroft EB; Zuber M; Nadeau S; Vaughan TG; Crawford KHD; Althaus CL; Reichmuth ML; Bowen JE; Walls AC; Corti D; Bloom JD; Veesler D; Mateo D; Hernando A; Comas I; González-Candelas F; ; Stadler T; Neher RA
    Nature; 2021 Jul; 595(7869):707-712. PubMed ID: 34098568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing.
    Loconsole D; Sallustio A; Accogli M; Centrone F; Casulli D; Madaro A; Tedeschi E; Parisi A; Chironna M
    Viruses; 2021 May; 13(5):. PubMed ID: 34066205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR.
    Amato L; Jurisic L; Puglia I; Di Lollo V; Curini V; Torzi G; Di Girolamo A; Mangone I; Mancinelli A; Decaro N; Calistri P; Di Giallonardo F; Lorusso A; D'Alterio N
    Emerg Microbes Infect; 2021 Dec; 10(1):1148-1155. PubMed ID: 34019466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.
    Ojelade M; Rodriguez A; Gonzalez D; Otokunrin D; Ramachandruni S; Cuevas E; Moon K; Tyler CG; Freeland M; Anderson M; Haire K; Orozco Y; Scipio F; Springer Y; Prot E; Shuford JA
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(10):348-349. PubMed ID: 33705368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.
    Borges V; Isidro J; Cortes-Martins H; Duarte S; Vieira L; Leite R; Gordo I; Caetano CP; Nunes B; Sá R; Oliveira A; Guiomar R; ; Gomes JP
    Emerg Microbes Infect; 2020 Dec; 9(1):2488-2496. PubMed ID: 33131453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?-a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools.
    Mégarbane B; Bourasset F; Scherrmann JM
    J Gen Intern Med; 2021 Mar; 36(3):746-752. PubMed ID: 33442818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioinformatics resources for SARS-CoV-2 discovery and surveillance.
    Hu T; Li J; Zhou H; Li C; Holmes EC; Shi W
    Brief Bioinform; 2021 Mar; 22(2):631-641. PubMed ID: 33416890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada.
    McLaughlin A; Montoya V; Miller RL; Mordecai GJ; ; Worobey M; Poon AFY; Joy JB
    Elife; 2022 Aug; 11():. PubMed ID: 35916373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy.
    Castelli M; Baj A; Criscuolo E; Ferrarese R; Diotti RA; Sampaolo M; Novazzi F; Dalla Gasperina D; Focosi D; Ferrari D; Locatelli M; Clementi M; Clementi N; Maggi F; Mancini N
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.